Table 7 Counts and age-standardized rate of nodular lymphocyte prominent Hodgkin lymphoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race.
From: Adult Hodgkin lymphoma incidence trends in the United States from 2000 to 2020
All race/ethnicities | ||||||
|---|---|---|---|---|---|---|
Age group (years) | Men | Women | ||||
Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | |
20+ | 2627 (64.66) | 0.25 (0.24, 0.26) | 4.95 (3.77, 6.45) | 1436 (35.34) | 0.13 (0.12, 0.14) | 6.33 (5.1, 7.94) |
20–29 | 466 (11.47) | 0.22 (0.2, 0.24) | 3.45 (1.57, 5.73) | 189 (4.65) | 0.09 (0.08, 0.11) | N/A |
30–39 | 525 (12.92) | 0.26 (0.23, 0.28) | 4.39 (1.93, 7.43) | 189 (4.65) | 0.09 (0.08, 0.11) | 2.59 (− 1.28, 7.51) |
40–49 | 534 (13.14) | 0.26 (0.24, 0.28) | 6.75 (5, 9) | 267 (6.57) | 0.13 (0.11, 0.14) | 8.98 (7.38, 11.27) |
50–59 | 520 (12.80) | 0.28 (0.26, 0.31) | 4.94 (3.14, 8.46) | 305 (7.51) | 0.16 (0.14, 0.18) | 6.6 (4.72, 9.37) |
60–69 | 366 (9.01) | 0.3 (0.27, 0.33) | 3.52 (1.75, 6.03) | 275 (6.77) | 0.2 (0.18, 0.23) | 5.21 (1.61, 11.44) |
70–79 | 169 (4.16) | 0.24 (0.21, 0.28) | 3.4 (0.8, 7.12) | 169 (4.16) | 0.19 (0.16, 0.22) | 5.83 (3.77, 8.74) |
80+ | 47 (1.16) | 0.13 (0.09, 0.17) | N/A | 42 (1.03) | 0.07 (0.05, 0.09) | N/A |
Hispanic | ||||||
|---|---|---|---|---|---|---|
Age groups | Men | Women | ||||
Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | |
20+ | 321 (64.46) | 0.15 (0.14, 0.17) | 3.57 (1.48, 6.56) | 177 (35.54) | 0.09 (0.08, 0.11) | 4.2 (0.71, 9.74) |
20–29 | 84 (16.87) | 0.14 (0.11, 0.17) | N/A | 23 (4.62) | 0.04 (0.03, 0.06) | N/A |
30–39 | 74 (14.86) | 0.14 (0.11, 0.17) | 3.4 (− 1.75, 10.64) | 25 (5.02) | 0.05 (0.03, 0.07) | N/A |
40–49 | 61 (12.25) | 0.14 (0.11, 0.18) | N/A | 44 (8.84) | 0.1 (0.07, 0.14) | N/A |
50–59 | 58 (11.65) | 0.2 (0.15, 0.26) | N/A | 34 (6.83) | 0.11 (0.08, 0.16) | N/A |
60–69 | 26 (5.22) | 0.17 (0.11, 0.25) | N/A | 30 (6.02) | 0.17 (0.11, 0.24) | N/A |
70–79 | 13 (2.61) | 0.18 (0.09, 0.31) | N/A | 16 (3.21) | 0.16 (0.09, 0.27) | N/A |
80+ | 5 (1.00) | 0.15 (0.05, 0.35) | N/A | 5 (1.00) | 0.09 (0.03, 0.21) | N/A |
NHB | ||||||
|---|---|---|---|---|---|---|
Age groups | Men | Women | ||||
Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | |
20+ | 498 (50.51) | 0.44 (0.41, 0.49) | 5.98 (3.93, 8.93) | 488 (49.49) | 0.38 (0.35, 0.42) | 6.14 (3.96, 9.31) |
20–29 | 82 (8.32) | 0.31 (0.25, 0.38) | 6.71 (3.33, 12.06) | 64 (6.49) | 0.24 (0.18, 0.3) | N/A |
30–39 | 106 (10.75) | 0.45 (0.37, 0.55) | 5.41 (0.85, 11.66) | 97 (9.84) | 0.37 (0.3, 0.46) | N/A |
40–49 | 130 (13.18) | 0.57 (0.47, 0.67) | N/A | 119 (12.07) | 0.46 (0.38, 0.55) | 9.35 (6.99, 13.01) |
50–59 | 103 (10.45) | 0.55 (0.45, 0.66) | N/A | 103 (10.45) | 0.47 (0.38, 0.57) | N/A |
60–69 | 56 (5.68) | 0.5 (0.37, 0.65) | N/A | 71 (7.20) | 0.49 (0.39, 0.62) | N/A |
70–79 | 18 (1.83) | 0.33 (0.19, 0.52) | N/A | 30 (3.04) | 0.36 (0.25, 0.52) | N/A |
80+ | 3 (0.30) | 0.12 (0.03, 0.37) | N/A | 4 (0.41) | 0.09 (0.02, 0.22) | N/A |
NHW | ||||||
|---|---|---|---|---|---|---|
Age groups | Men | Women | ||||
Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | Case (%) | Delayed ASIR (95% CI) | AAPC (95%CI) | |
20+ | 1684 (70.43) | 0.27 (0.26, 0.28) | 4.87 (4.02, 5.84) | 707 (29.57) | 0.1 (0.09, 0.11) | 6.25 (4.73, 8.28) |
20–29 | 273 (11.42) | 0.26 (0.23, 0.29) | 2.01 (− 0.26, 4.63) | 92 (3.85) | 0.09 (0.07, 0.11) | N/A |
30–39 | 324 (13.55) | 0.3 (0.27, 0.34) | 4.93 (1.65, 8.98) | 60 (2.51) | 0.06 (0.04, 0.07) | N/A |
40–49 | 318 (13.30) | 0.26 (0.24, 0.29) | 6.57 (4.85, 8.63) | 95 (3.97) | 0.08 (0.06, 0.1) | N/A |
50–59 | 333 (13.93) | 0.28 (0.25, 0.31) | 4.85 (3.06, 7.96) | 148 (6.19) | 0.12 (0.1, 0.14) | 6.74 (3.38, 11.79) |
60–69 | 269 (11.25) | 0.31 (0.27, 0.35) | 3.32 (1.18, 6.27) | 160 (6.69) | 0.17 (0.15, 0.2) | N/A |
70–79 | 131 (5.48) | 0.25 (0.21, 0.3) | 3.53 (0.58, 7.66) | 120 (5.02) | 0.19 (0.16, 0.23) | 5.45 (2.44, 9.9) |
80+ | 36 (1.51) | 0.13 (0.09, 0.18) | N/A | 32 (1.34) | 0.07 (0.05, 0.1) | N/A |
